fg-3019
Showing 1 - 9 of 9
Focal Segmental Glomerulosclerosis Trial in New Hyde Park, Chapel Hill, Columbus (FG-3019)
Terminated
- Focal Segmental Glomerulosclerosis
- FG-3019
-
New Hyde Park, New York
- +2 more
Jul 29, 2019
Diabetes, Diabetic Nephropathy Trial in United States (FG-3019)
Completed
- Diabetes Mellitus
- Diabetic Nephropathy
- FG-3019
-
Birmingham, Alabama
- +17 more
Jul 31, 2019
Idiopathic Pulmonary Fibrosis Trial in United States (FG-3019)
Completed
- Idiopathic Pulmonary Fibrosis
- FG-3019
-
Birmingham, Alabama
- +17 more
Oct 1, 2019
Type 2 Diabetes, Diabetic Nephropathy, Diabetic Kidney Disease Trial in United States (FG-3019, Placebo)
Terminated
- Type 2 Diabetes Mellitus
- +2 more
- FG-3019
- Placebo
-
Tempe, Arizona
- +27 more
Feb 20, 2019
Pancreatic Cancer Trial (FG-3019)
Withdrawn
- Pancreatic Cancer
- FG-3019
- (no location specified)
Oct 6, 2016
Liver Fibrosis Due to Chronic Hepatitis B Infection Trial in Hong Kong, Thailand (FG-3019, Placebo, Entecavir)
Terminated
- Liver Fibrosis Due to Chronic Hepatitis B Infection
- FG-3019
- +2 more
-
Pokfulam, Hong Kong Island, Hong Kong
- +8 more
Aug 12, 2016
Locally Advanced or Metastatic Pancreatic Cancer Trial in United States (FG-3019)
Completed
- Locally Advanced or Metastatic Pancreatic Cancer
- FG-3019
-
Stanford, California
- +6 more
Aug 4, 2014
Idiopathic Pulmonary Fibrosis Trial in United States (FG-3019)
Completed
- Idiopathic Pulmonary Fibrosis
- FG-3019
-
Denver, Colorado
- +3 more
Dec 10, 2007
Diabetes Trial in United States (FG-3019)
Completed
- Diabetes Mellitus
- FG-3019
-
Los Angeles, California
- +4 more
Dec 10, 2007